Egyptian International Pharmaceutical Investments

CAI:PHAR (Egypt)  
E£ 36.40 (-2.33%) Jun 6
6.05
P/B:
1.27
Market Cap:
E£ 5.41B ($ 113.92M)
Enterprise V:
E£ 9.62B ($ 202.37M)
Volume:
493.16K
Avg Vol (2M):
375.09K
Volume:
493.16K
Avg Vol (2M):
375.09K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Egyptian International Pharmaceutical Investments ( ) from 1995 to Jun 09 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Egyptian International Pharmaceutical Investments stock (CAI:PHAR) PE ratio as of Jun 09 2024 is 6.05. More Details

Egyptian International Pharmaceutical Investments (CAI:PHAR) PE Ratio (TTM) Chart

To

Egyptian International Pharmaceutical Investments (CAI:PHAR) PE Ratio (TTM) Historical Data

Total 1289
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Egyptian International Pharmaceutical Investments PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-09 6.0 2024-04-07 7.2
2024-06-06 6.0 2024-04-04 7.4
2024-06-05 6.2 2024-04-03 7.2
2024-06-04 6.3 2024-04-02 7.3
2024-06-03 6.2 2024-04-01 7.3
2024-06-02 6.2 2024-03-31 7.3
2024-05-30 6.3 2024-03-28 7.7
2024-05-29 6.4 2024-03-27 7.8
2024-05-28 6.5 2024-03-26 7.9
2024-05-27 6.5 2024-03-25 8.0
2024-05-26 6.2 2024-03-24 7.9
2024-05-23 6.2 2024-03-21 8.1
2024-05-22 6.3 2024-03-20 8.2
2024-05-21 6.2 2024-03-19 7.9
2024-05-20 6.1 2024-03-18 7.9
2024-05-19 6.0 2024-03-17 8.1
2024-05-16 5.8 2024-03-14 8.1
2024-05-15 5.6 2024-03-13 8.1
2024-05-14 5.6 2024-03-12 8.0
2024-05-13 5.6 2024-03-11 8.2
2024-05-12 5.7 2024-03-10 8.3
2024-05-09 5.8 2024-03-07 7.8
2024-05-08 5.7 2024-03-06 7.8
2024-05-07 5.8 2024-03-05 8.1
2024-05-06 6.0 2024-03-04 8.1
2024-05-05 6.0 2024-03-03 8.2
2024-05-02 6.0 2024-02-29 8.0
2024-05-01 5.7 2024-02-28 8.2
2024-04-30 5.7 2024-02-27 8.7
2024-04-29 6.4 2024-02-26 8.6
2024-04-28 5.7 2024-02-25 7.9
2024-04-25 7.0 2024-02-22 7.9
2024-04-24 7.0 2024-02-21 8.1
2024-04-23 7.2 2024-02-20 7.8
2024-04-22 7.5 2024-02-19 7.6
2024-04-21 7.4 2024-02-18 7.9
2024-04-18 7.5 2024-02-15 7.9
2024-04-17 7.8 2024-02-14 7.3
2024-04-16 7.5 2024-02-13 7.0
2024-04-15 7.3 2024-02-12 6.8
2024-04-14 7.3 2024-02-11 6.9
2024-04-11 7.3 2024-02-08 7.0
2024-04-10 7.3 2024-02-07 6.8
2024-04-09 7.3 2024-02-06 6.8
2024-04-08 7.3 2024-02-05 7.0

Egyptian International Pharmaceutical Investments (CAI:PHAR) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Egyptian International Pharmaceutical Investments is an Egypt based company pharmaceutical generic drugs. It holds license agreements with a group of pharmaceutical companies to produce their products locally and replace the imported ones. The company produces dosage forms, Spansule capsules, Antibiotics, Lyophilized Products. It exports its products to African, Asian and East European and Latin American Countries.